What are analysts Suggestions on Five9, Inc.(NASDAQ:FIVN): Collegium Pharmaceutical, Inc.(NASDAQ:COLL)

0
11

Five9, Inc. (FIVN) will report its next earnings on May 01 AMC. The company reported the earnings of $0.16/Share in the last quarter where the estimated EPS by analysts was $0.13/share. The difference between the expected and actual EPS was $0.03/share, which represents an Earnings surprise of 23.1%.

Many analysts are providing their Estimated Earnings analysis for Five9, Inc. and for the current quarter 15 analysts have projected that the stock could give an Average Earnings estimate of $0.12/share. These analysts have also projected a Low Estimate of $0.11/share and a High Estimate of $0.13/share.

In case of Revenue Estimates, 13 analysts have provided their consensus Average Revenue Estimates for Five9, Inc. as 72.47 Million. According to these analysts, the Low Revenue Estimate for Five9, Inc. is 70.59 Million and the High Revenue Estimate is 73 Million. The company had Year Ago Sales of 61.12 Million.

These analysts also forecasted Growth Estimates for the Current Quarter for FIVN to be 9.1%. They are projecting Next Quarter growth of -16.67%. For the next 5 years, Five9, Inc. is expecting Growth of 26.4% per annum, whereas in the past 5 years the growth was 6.67% per annum.

Some buy side analysts are also providing their Analysis on Five9, Inc., where 2 analysts have rated the stock as Strong buy, 0 analysts have given a Buy signal, 0 said it’s a HOLD, and 0 analysts rated the stock as Sell. (These Recommendations are for the Current Month Only reported by Yahoo Finance.)

When it comes to the Analysis of a Stock, Price Target plays a vital role. Analysts reported that the Price Target for Five9, Inc. might touch $65 high while the Average Price Target and Low price Target is $58.08 and $39 respectively.

Five9, Inc. closed its last trading session at $51.06 with the loss of -2.88%. The Market Capitalization of the company stands at 3.01 Billion. The Company has 52-week high of $57.90 and 52-week low of $31.64. The stock’s current distance from 20-Day Simple Moving Average (SMA20) is -2.16% where SMA50 and SMA200 are -3.93% and 6.9% respectively. The Company Touched its 52-Week High on 02/20/19 and 52-Week Low on 07/31/18.

The Relative Volume of the company is 1.75 and Average Volume (3 months) is 793.59 million. The company’s P/E (price to earnings) ratio is 0 and Forward P/E ratio of 60.11.

The company shows its Return on Assets (ROA) value of -0.4%. The Return on Equity (ROE) value stands at -1.1%. While it’s Return on Investment (ROI) value is 1.9%.

While looking at the Stock’s Performance, Five9, Inc. currently shows a Weekly Performance of -2.48%, where Monthly Performance is -3.18%, Quarterly performance is -6.43%, 6 Months performance is 29.07% and yearly performance percentage is 53.62%. Year to Date performance value (YTD perf) value is 13.43%. The Stock currently has a Weekly Volatility of 2.49% and Monthly Volatility of 3.27%.

Collegium Pharmaceutical, Inc. (COLL) will report its next earnings on May 08 AMC. The company reported the earnings of $-0.29/Share in the last quarter where the estimated EPS by analysts was $-0.24/share. The difference between the expected and actual EPS was $-0.05/share, which represents an Earnings surprise of -20.8%.

Many analysts are providing their Estimated Earnings analysis for Collegium Pharmaceutical, Inc. and for the current quarter 5 analysts have projected that the stock could give an Average Earnings estimate of $-0.09/share. These analysts have also projected a Low Estimate of $-0.28/share and a High Estimate of $0.25/share.

In case of Revenue Estimates, 8 analysts have provided their consensus Average Revenue Estimates for Collegium Pharmaceutical, Inc. as 76.31 Million. According to these analysts, the Low Revenue Estimate for Collegium Pharmaceutical, Inc. is 74.8 Million and the High Revenue Estimate is 78.35 Million. The company had Year Ago Sales of 73.06 Million.

These analysts also forecasted Growth Estimates for the Current Quarter for COLL to be -26.7%. They are projecting Next Quarter growth of 52%. For the next 5 years, Collegium Pharmaceutical, Inc. is expecting Growth of 181.79% per annum, whereas in the past 5 years the growth was 53.49% per annum.

Some buy side analysts are also providing their Analysis on Collegium Pharmaceutical, Inc., where 4 analysts have rated the stock as Strong buy, 0 analysts have given a Buy signal, 0 said it’s a HOLD, and 0 analysts rated the stock as Sell. (These Recommendations are for the Current Month Only reported by Yahoo Finance.)

When it comes to the Analysis of a Stock, Price Target plays a vital role. Analysts reported that the Price Target for Collegium Pharmaceutical, Inc. might touch $35 high while the Average Price Target and Low price Target is $28.14 and $22 respectively.

Collegium Pharmaceutical, Inc. closed its last trading session at $11.67 with the gain of 1.2%. The Market Capitalization of the company stands at 399.3 Million. The Company has 52-week high of $28.91 and 52-week low of $11.53. The stock’s current distance from 20-Day Simple Moving Average (SMA20) is -13.39% where SMA50 and SMA200 are -20.96% and -26.72% respectively. The Company Touched its 52-Week High on 06/20/18 and 52-Week Low on 05/23/19.

The Relative Volume of the company is 0.81 and Average Volume (3 months) is 424.67 million. The company’s P/E (price to earnings) ratio is 0 and Forward P/E ratio of 14.71.

The company shows its Return on Assets (ROA) value of -6.3%. The Return on Equity (ROE) value stands at -36.4%. While it’s Return on Investment (ROI) value is -20.1%.

While looking at the Stock’s Performance, Collegium Pharmaceutical, Inc. currently shows a Weekly Performance of -6.79%, where Monthly Performance is -18.44%, Quarterly performance is -23.86%, 6 Months performance is -30.53% and yearly performance percentage is -53.1%. Year to Date performance value (YTD perf) value is -31.22%. The Stock currently has a Weekly Volatility of 4.17% and Monthly Volatility of 5.56%.

SHARE